Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Irene Torres Ramón"'
Autor:
Marta Gascón-Ruiz, Diego Casas-Deza, Maria Marti-Pi, Irene Torres-Ramón, María Zapata-García, Andrea Sesma, Julio Lambea, María Álvarez-Alejandro, Elisa Quilez, Dolores Isla, Jose Miguel Arbonés-Mainar
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2201 (2022)
Background and Aims: Malnutrition is a condition that has a great impact on oncology patients. Poor nutritional status is often associated with increased morbidity and mortality, increased toxicity, and reduced tolerance to chemotherapy, among other
Externí odkaz:
https://doaj.org/article/8ddec1fa644c40ffba979418f58fd5a6
Autor:
Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra, Luis Martínez-Lostao, J. Ramón Paño-Pardo, Andrea Sesma, María Zapata-García, Alba Moratiel, Elisa Quílez, Irene Torres-Ramón, Alfonso Yubero, María Pilar Domingo, Patricia Esteban, Eva M. Gálvez, Julián Pardo, Dolores Isla
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 329
5 figures, 5 tables.-- Supplementary information available.
(1) Despite the effectiveness of immune checkpoint inhibitors (ICIs) in lung cancer, there is a lack of knowledge about predictive biomarkers. The objective of our study is to analyze d
(1) Despite the effectiveness of immune checkpoint inhibitors (ICIs) in lung cancer, there is a lack of knowledge about predictive biomarkers. The objective of our study is to analyze d
Autor:
Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Publikováno v:
Cells, Vol 9, Iss 6, p 1525 (2020)
The molecular and cell determinants that modulate immune checkpoint (ICI) efficacy in lung cancer are still not well understood. However, there is a necessity to select those patients that will most benefit from these new treatments. Recent studies s
Externí odkaz:
https://doaj.org/article/c185481f819c47e49b8a770ab89cbf7a
Autor:
Maria Zapata-Garcia, Jose M. Arbones-Mainar, Elisa Quilez, Irene Torres-Ramón, Andrea Sesma, Marta Gascón-Ruiz, Natalia Alonso, J. Lambea, María Álvarez-Alejandro, Diego Casas-Deza, Dolores Isla
Publikováno v:
European Journal of Clinical Nutrition. 76:698-702
Background Many studies have assessed different malnutrition screening tools in oncologic patients. However, very few have been carried out using the new GLIM criteria for malnutrition. The objective of our study is to compare the most recommended sc
Autor:
Jorge de Francisco Moure, Irene Torres Ramón, Berenice Abreu Rodríguez, Sonia Navarrete Navarro, Carmen Almárcegui Lafita
Introduction:Neurological symptoms are common in patients who have suffered a SARS-CoV-2 infection. Cases of Guillain-Barré syndrome as well as sensory symptoms have been published in the context of a long COVID-19 syndrome.Patients and methods:We p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a02e711deafb5ced4beea3f4077fbedd
https://doi.org/10.21203/rs.3.rs-1403581/v1
https://doi.org/10.21203/rs.3.rs-1403581/v1
Autor:
Marta, Gascón-Ruiz, Diego, Casas-Deza, Irene, Torres-Ramón, María, Zapata-García, Natalia, Alonso, Andrea, Sesma, Julio, Lambea, María, Álvarez-Alejandro, Elisa, Quílez, Dolores, Isla, Jose M, Arbonés-Mainar
Publikováno v:
European journal of clinical nutrition. 76(5)
Many studies have assessed different malnutrition screening tools in oncologic patients. However, very few have been carried out using the new GLIM criteria for malnutrition. The objective of our study is to compare the most recommended screening too
Publikováno v:
Sn Comprehensive Clinical Medicine
Guillain-Barré syndrome (GBS) is a well-established complication of infectious disease. So it is not surprising that several cases have been described during the actual SARS-CoV-2 infection pandemic. Most of the descriptions are patients suffering a
Autor:
Elisa Quilez, Marta Gascón-Ruiz, Natalia Alonso, Maria Zapata-Garcia, Dolores Isla, Andrea Sesma, María Álvarez-Alejandro, Irene Torres-Ramón, Diego Casas-Deza, Jose M. Arbones-Mainar, J. Lambea
Publikováno v:
Clinical nutrition (Edinburgh, Scotland). 40(6)
Summary Background & aims Malnutrition is one of the most prevalent problems among oncological patients. It reduces the response to treatments and negatively impacts survival. In 2019, a consensus criteria for diagnosing malnutrition (GLIM criteria)
Autor:
María Álvarez Alejandro, Marta Cruellas Lapeña, Pablo Andrés Ordóñez Lozano, Marta Gascón Ruiz, Raquel Andrés Conejero, Elisa Quílez Bielsa, Dolores Isla Casado, Irene Torres Ramón, Pilar Bueso Inglán, Maitane Ocariz Diez, Andrea Sesma Goñi, Carlos Álvarez Ruiz, Ismael Gil Romea, Natalia Alonso Marin, Luis M. Esteban, María Zapata García, Maria Zurera Berjaga
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
instname
Introducción No existe un consenso sobre las indicaciones de mastectomía contralateral en pacientes diagnosticadas de cáncer de mama unilateral sin mutación germinal en BRCA1/2. Estudios previos han identificado algunos factores que pueden influi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6355fe3546f38c7aa9e3c30ea04eba
http://zaguan.unizar.es/record/106584
http://zaguan.unizar.es/record/106584
Autor:
Dolores Isla, Julián Pardo, Marta Gascón, Andrea Sesma, Irene Torres-Ramón, Mara Cruellas, Elisa Quilez, María A. Zapata, Maitane Ocáriz, José Ramón Paño, Luis Martínez-Lostao, Ariel Ramírez, Alfonso Yubero, Eva M. Galvez, R. Lastra
Publikováno v:
Cancers, Vol 12, Iss 2974, p 2974 (2020)
Cancers
Cancers
2 tables.
Immune control inhibitor drugs (anti-PD1/PD-L1/CTLA-4) (ICIs) are showing efficacy in the treatment of lung cancer. Currently the only biomarker with clinical utility for ICIs, such as the expression of PDL1, does not appear to be perf
Immune control inhibitor drugs (anti-PD1/PD-L1/CTLA-4) (ICIs) are showing efficacy in the treatment of lung cancer. Currently the only biomarker with clinical utility for ICIs, such as the expression of PDL1, does not appear to be perf